Murray Epstein

18.2k total citations · 5 hit papers
261 papers, 13.3k citations indexed

About

Murray Epstein is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Murray Epstein has authored 261 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Cardiology and Cardiovascular Medicine, 85 papers in Pulmonary and Respiratory Medicine and 78 papers in Nephrology. Recurrent topics in Murray Epstein's work include Blood Pressure and Hypertension Studies (64 papers), Electrolyte and hormonal disorders (47 papers) and Renal function and acid-base balance (37 papers). Murray Epstein is often cited by papers focused on Blood Pressure and Hypertension Studies (64 papers), Electrolyte and hormonal disorders (47 papers) and Renal function and acid-base balance (37 papers). Murray Epstein collaborates with scholars based in United States, Canada and Japan. Murray Epstein's co-authors include James R. Sowers, Rodger Loutzenhiser, Edward D. Fröhlich, Vicente Arroyo, Jens H. Henriksen, Joan Rodés, Mauro Bernardi, Kôichi Hayashi, Robert W. Schrier and George L. Bakris and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Murray Epstein

257 papers receiving 12.5k citations

Hit Papers

Peripheral arterial vasod... 1970 2026 1988 2007 1988 2000 2001 2020 1970 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
    1988 1.2k citations Robert W. Schrier, Vicente Arroyo et al. Hepatology profile →
  2. Preserving renal function in adults with hypertension and diabetes: A consensus approach
    2000 1.1k citations George L. Bakris, Murray Epstein et al. American Journal of Kidney Diseases profile →
  3. Diabetes, Hypertension, and Cardiovascular Disease
    2001 1.0k citations Murray Epstein et al. profile →
  4. Renin-Angiotensin System Blockers and the COVID-19 Pandemic
    2020 354 citations Murray Epstein et al. profile →
  5. Renal failure in the patient with cirrhosis
    1970 344 citations Murray Epstein, Norman K. Hollenberg et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Murray Epstein 5.0k 3.4k 2.8k 2.6k 2.4k 261 13.3k
Matthew R. Weir 3.5k 0.7× 2.4k 0.7× 3.0k 1.1× 3.8k 1.5× 4.1k 1.8× 362 15.4k
Stephen C. Textor 5.0k 1.0× 2.4k 0.7× 3.4k 1.2× 6.6k 2.5× 5.2k 2.2× 282 17.7k
Michel Chonchol 2.8k 0.6× 2.0k 0.6× 5.8k 2.1× 1.7k 0.6× 2.2k 0.9× 320 14.2k
Ömer Toprak 4.5k 0.9× 4.6k 1.4× 4.6k 1.7× 1.8k 0.7× 2.7k 1.1× 31 19.4k
Hüseyin Kurt 4.4k 0.9× 4.6k 1.4× 4.1k 1.5× 1.6k 0.6× 2.6k 1.1× 16 18.7k
Michael W. Steffes 3.4k 0.7× 7.2k 2.1× 5.5k 2.0× 1.6k 0.6× 4.2k 1.8× 154 19.7k
Norman K. Hollenberg 8.5k 1.7× 5.2k 1.5× 2.6k 0.9× 2.2k 0.8× 1.8k 0.8× 373 16.8k
Cihat Şarkış 4.4k 0.9× 4.6k 1.4× 4.1k 1.5× 1.6k 0.6× 2.6k 1.1× 10 18.7k
Rijk O. B. Gans 3.1k 0.6× 3.8k 1.1× 3.0k 1.1× 2.0k 0.8× 2.2k 0.9× 358 15.3k
Danilo Fliser 4.3k 0.9× 1.7k 0.5× 6.6k 2.4× 2.3k 0.9× 2.7k 1.2× 301 18.6k

Countries citing papers authored by Murray Epstein

Since Specialization
Citations

This map shows the geographic impact of Murray Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Epstein more than expected).

Fields of papers citing papers by Murray Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Epstein. The network helps show where Murray Epstein may publish in the future.

Co-authorship network of co-authors of Murray Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Murray Epstein. A scholar is included among the top collaborators of Murray Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray Epstein. Murray Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antonelli, Maria, Irving Kushner, & Murray Epstein. (2023). The constellation of vitamin D, the acute-phase response, and inflammation. Cleveland Clinic Journal of Medicine. 90(2). 85–89. 5 indexed citations
2.
Bushinsky, David A., et al.. (2023). Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials. American Journal of Kidney Diseases. 82(1). 97–104. 6 indexed citations
3.
Epstein, Murray, Roberto Pecoits‐Filho, Catherine M. Clase, Manish M. Sood, & Csaba P. Kövesdy. (2021). Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD. Clinical Journal of the American Society of Nephrology. 17(3). 455–457. 10 indexed citations
4.
Rossignol, Patrick, Matthieu Legrand, Mikhail Kosiborod, et al.. (2016). Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. Pharmacological Research. 113(Pt A). 585–591. 90 indexed citations
5.
Epstein, Murray. (2016). Hyperkalemia: current concepts and emerging therapeutic options. Kidney International Supplements. 6(1). 1–2. 2 indexed citations
6.
Epstein, Murray, Martha Mayo, Dahlia Garza, et al.. (2015). Abstract 14271: Patiromer Controls Hyperkalemia in Resistant Hypertensive Patients on RAASi, With Diabetic Kidney Disease. Circulation. 132(suppl_3). 6 indexed citations
7.
Epstein, Murray & David A. Calhoun. (2007). The role of aldosterone in resistant hypertension: Implications for pathogenesis and therapy. Current Hypertension Reports. 9(2). 98–105. 15 indexed citations
8.
Hollenberg, Norman K. & Murray Epstein. (2006). Renin Angiotensin System Blockade and Nephropathy. Clinical Journal of the American Society of Nephrology. 1(5). 1046–1048. 5 indexed citations
9.
Epstein, Murray & B. Waeber. (2002). Fixed-dose combination therapy with calcium antagonists.. IRIS. 2 indexed citations
10.
Epstein, Murray, et al.. (2002). Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction. Journal of the American College of Cardiology. 39. 249–249. 32 indexed citations
11.
Epstein, Murray. (2000). The Growing Role of Calcium Antagonists in Treating Hypertension in the Elderly. The American Journal of Geriatric Cardiology. 9(1). 42–48. 3 indexed citations
12.
Epstein, Murray. (1998). A symposium : calcium antagonists and the diabetic patient : recent controversies and future perspectives. 1 indexed citations
13.
Wee, Pieter M. ter, H Förster, & Murray Epstein. (1997). Video-microscopic Assessment of the Role of Tissue Angiotensin-converting Enzyme in the Control of the Renal Microcirculation. Journal of Pharmacology and Experimental Therapeutics. 281(1). 434–439. 4 indexed citations
14.
Epstein, Murray. (1996). The Kidney in liver disease. 107 indexed citations
15.
Schrier, Robert W., Vicente Arroyo, Mauro Bernardi, et al.. (1988). Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 8(5). 1151–1157. 1187 indexed citations breakdown →
16.
Loutzenhiser, Rodger, Kôichi Hayashi, & Murray Epstein. (1988). Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.. Journal of Pharmacology and Experimental Therapeutics. 246(2). 522–528. 76 indexed citations
17.
Loutzenhiser, Rodger, Murray Epstein, & Charles Horton. (1987). Modification by Dihydropyridine-Type Calcium Antagonists of the Renal Hemodynamic Response to Vasoconstrictors. Journal of Cardiovascular Pharmacology. 9. S70–S75. 10 indexed citations
18.
Epstein, Murray. (1983). Renal sodium handling in cirrhosis. Seminars in Nephrology. 3(3). 225–240. 21 indexed citations
19.
Shapiro, Arthur, et al.. (1977). Management of Hyperstimulation Syndrome. Fertility and Sterility. 28(3). 237–239. 11 indexed citations
20.
Epstein, Murray, et al.. (1974). Alterations in acid-base homeostasis during water immersion in normal man. Journal of Laboratory and Clinical Medicine. 84. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew R. Weir Breakdown of academic impact, for papers by Stephen C. Textor Breakdown of academic impact, for papers by Michel Chonchol Breakdown of academic impact, for papers by Ömer Toprak Breakdown of academic impact, for papers by Hüseyin Kurt Breakdown of academic impact, for papers by Michael W. Steffes Breakdown of academic impact, for papers by Norman K. Hollenberg Breakdown of academic impact, for papers by Cihat Şarkış Breakdown of academic impact, for papers by Rijk O. B. Gans Breakdown of academic impact, for papers by Danilo Fliser
Rankless by CCL
2026